IP Library Granted Patent US 8,304,424
Granted Patent B2
US 8,304,424 · App. 12/514,668 · Granted Nov 6, 2012

Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature

Assignee: Pierre Fabre Medicament
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,304,424
App. No.
12/514,668
Granted
Nov 6, 2012
Kind
B2
Abstract

This invention relates to pharmaceutical compositions consisting of a semisynthetic derivative of vinca alkaloid, stable at room temperature, in which said derivative is present in the form of a freeze dried product obtained in the presence of at least one carbohydrate.

Claims (11)

1. Pharmaceutical compositions consisting of a hydrosoluble salt of vinflunine or vinorelbine, stable at room temperature, wherein said hydrosoluble salt of vinflunine or vinorelbine is in a freeze-dried form obtained in the presence of at least one carbohydrate, at least one buffer system and a hydrophilic anti-oxidation agent.

2. Compositions according to claim 1 wherein the hydrosoluble salt of vinflunine or vinorelbine is vinflunine ditartrate or vinorelbine ditartrate.

3. Compositions according to claim 1 wherein the carbohydrate (s) is chosen from among the monosaccharides, reduced or not, oligosaccharides or polysaccharides.

4. Compositions according to claim 3 wherein the carbohydrate (s) is chosen from among saccharose, trehalose and lactose.

5. Compositions according to claim 1 wherein the buffer system chosen to control the pH has a value between 3 and 4 and a molarity between 0.005 M and 0.5 M.

6. Compositions according to claim 1 wherein said compositions are manufactured and packaged under an inert gas atmosphere and/or with incorporation of a hydrophilic anti-oxidation agent into the formula.

7. Compositions according to claim 1 wherein said compositions are in a form suited to administration by infusion by intravenous route.

8. Compositions according to claim 3 wherein the carbohydrate (s) is disaccharides.

9. Compositions according to claim 3 wherein the carbohydrate (s) is inuline.

10. Compositions according to claim 5 wherein the buffer system chosen to control the pH has a value in the region of 3.5 and a molarity between 0.05 M and 0.2 M.

11. Pharmaceutical compositions consisting of a hydrosoluble salt of vinflunine or vinorelbine, stable at room temperature, wherein said hydrosoluble salt of vinflunine or vinorelbine is in a freeze-dried form obtained in the presence of at least one carbohydrate.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE FIRST INVENTOR'S NAME TO READ AS ELIE LEVERD PREVIOUSLY RECORDED ON REEL 023217 FRAME 0129. ASSIGNOR(S) HEREBY CONFIRMS THE FIRST INVENTOR'S NAME TO READ AS ELIE LEVERD. Recorded Jan 25, 2010
From: LEVERD, ELIE; BOUGARET, JOEL; IBARRA, MARIE-DOMINIQUE
To: PIERRE FABRE MEDICAMENT
Reel/Frame 023838/0404 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY'S ADDRESS. DOCUMENT PREVIOUSLY RECORDED AT REEL 022948 FRAME 0927 Recorded Sep 4, 2009
From: LEVERD, ELLE; BOUGARET, JOEL; IBARRA, MARIE-DOMINIQUE
To: PIERRE FABRE MEDICAMENT
Reel/Frame 023217/0129 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2009
From: LEVERD, ELIE; BOUGARET, JOEL; IBARRA, MARIE-DOMINIQUE
To: PIERRE FABRE MEDICAMENT
Reel/Frame 022948/0927 →
Priority Claims (1)
FR 06 56044 · Dec 29, 2006 · national
Continuity (2)
Provisional Application 60897059 · Jan 24, 2007
Related Publication 20100087473A1 · Apr 8, 2010